Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Lumos Pharma (LUMO) shares

Learn how to easily invest in Lumos Pharma shares.

Lumos Pharma Inc

NASDAQ: LUMO - USD

$7.84

+ $0.16 ( + 2.08%)

BIOTECHNOLOGY

Buy Lumos Pharma Shares

Jing Jun Ma

Updated Dec 30, 2021

Fact checked

Lumos Pharma is a biotechnology business based in the US. Lumos Pharma stocks (LUMO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $11.05 – a decrease of 1.29% over the previous week. Lumos Pharma employs 32 staff and has a trailing 12-month revenue of around $341,000.

How to buy stocks in Lumos Pharma

Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
Open your brokerage account. Complete an application with your details.
Confirm your payment details. Fund your account.
Research the stock. Find the stock by name or ticker symbol – LUMO – and research it before deciding if it's a good investment for you.
Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
Check in on your investment. Optimize your portfolio by tracking your stock.

Finder's Pick for

Beginners

CIBC Investor's Edge

Finder's Pick for

Free Trades

Wealthsimple Trade

Finder's Pick for

Commodity Stocks

Scotia iTRADE

Finder's Pick for

Global Trading

Interactive Brokers

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. You can learn more about our methodology here. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

Our pick for beginners. We chose CIBC Investor's Edge for this category because it offers low and competitive fees, as well as an easy-to-use, user-friendly interface and provides a number of learning resources to help you get acquainted with the platform. In addition, students can take advantage of special pricing for making trades if they have a CIBC Student Bank account.
Our pick for free trades. We chose Wealthsimple Trade for this category because it offers commission-free trading. With no account fee, the mobile app is clean and intuitive to use.
Our pick for commodity stocks. We chose Scotia iTRADE for this category because it offers an easy-to-use, user-friendly UX and provides access to a variety of learning resources to help you get acquainted with trading and how the platform works.
Our pick for global trading. We chose Interactive Brokers for this category because it offers extensive trading capabilities and access to advanced trading tools to help traders in their investing journey, as well as access to a large number of international stock exchanges.

What's in this guide?

Can I buy shares in Lumos Pharma?
Has coronavirus impacted Lumos Pharma shares?
Lumos Pharma shares summary
Compare share dealing platforms
Is Lumos Pharma stock a buy or sell?
Lumos Pharma performance over time
Lumos Pharma's financials
How volatile are Lumos Pharma shares?
Does Lumos Pharma pay a dividend?
Have Lumos Pharma shares ever split?
Other common questions

Lumos Pharma stock price (NASDAQ:LUMO)

Use our graph to track the performance of LUMO stocks over time.

Lumos Pharma shares at a glance

Key figures

Information last updated 2022-05-24.

Latest market close	$7.68
52-week range	$6.15 - $12.05
50-day moving average	$8.76
200-day moving average	$8.83
Wall St. target price	$24.33
PE ratio	N/A
Dividend yield	$0 (0%)
Earnings per share (TTM)	$-3.54

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6

Name	Product	Finder Rating	Stock Trading Fee	Account Fee	Available Asset Types	Offer
OFFER CIBC Investor's Edge CIBC Investor's Edge	OFFER	Finder Rating: ★★★★★ 4 / 5	$4.95 - $6.95	$0 if conditions met, otherwise $100/year	Stocks, Bonds, Options, Mutual Funds, ETFs	Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.	Go to site More Info	Compare	loading Fetching your data...
FREE TRADES Wealthsimple Trade Wealthsimple Trade	FREE TRADES	Finder Rating: ★★★★★ 3.9 / 5	$0	$0	Stocks, ETFs	Get 2 free stocks when you deposit and trade $150.	Go to site More Info	Compare	loading Fetching your data...
Scotia iTRADE Scotia iTRADE		Finder Rating: ★★★★★ 3.8 / 5	$4.99 - $9.99	$0	Bonds, Options, Mutual Funds, ETFs, GICs, International Equities		Go to site More Info	Compare	loading Fetching your data...
Interactive Brokers Interactive Brokers		Finder Rating: ★★★★★ 4.1 / 5	Min. $1.00, Max. 0.5%	$0	Stocks, Bonds, Options, ETFs, Currencies, Futures		Go to site More Info	Compare	loading Fetching your data...
Questrade Questrade		Finder Rating: ★★★★★ 4.2 / 5	$4.95 - $9.95	$0	Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals	Get $50 in free trades when you fund your account with a minimum of $1,000.	Go to site More Info	Compare	loading Fetching your data...
OFFER Qtrade Direct Investing Qtrade Direct Investing	OFFER	Finder Rating: ★★★★★ 4.1 / 5	$6.95 - $8.75	$0 if conditions met, otherwise $25/quarter	Stocks, Bonds, Options, Mutual Funds, ETFs, GICs	Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends August 31, 2022.	Go to site More Info	Compare	loading Fetching your data...

Compare up to 4 providers

Online stock trading

Is it a good time to buy Lumos Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Lumos Pharma price performance over time

Historical closes compared with the close of $7.68 from 2022-05-26

1 week (2022-05-18)	0.92%
1 month (2022-04-26)	-13.61%
3 months (2022-02-24)	-21.79%
6 months (2021-11-26)	2.42%

1 year (2021-05-27)	-25.29%
2 years (2020-05-27)	-48.11%
3 years (2019-05-24)	306.35%
5 years (2017-05-26)	14.34

Lumos Pharma financials

Revenue TTM	$341,000
Gross profit TTM	$230,000
Return on assets TTM	-17.85%
Return on equity TTM	-30.94%
Profit margin	0%
Book value	$9.79
Market capitalisation	$66.1 million

TTM: trailing 12 months

Lumos Pharma share dividends

We're not expecting Lumos Pharma to pay a dividend over the next 12 months.

Have Lumos Pharma's shares ever split?

Lumos Pharma's shares were split on a 1:9 basis on 19 March 2020. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Lumos Pharma shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for Lumos Pharma shares which in turn could have impacted Lumos Pharma's share price.

Lumos Pharma share price volatility

Over the last 12 months, Lumos Pharma's shares have ranged in value from as little as $6.15 up to $12.05. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lumos Pharma's is 0.9773. This would suggest that Lumos Pharma's shares are less volatile than average (for this exchange).

Lumos Pharma overview

Lumos Pharma, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas. .

Lumos Pharma in the news

Former White House press secretary Jen Psaki will join MSNBC this fall

Lumos Pharma to Participate in Upcoming Investor Conferences

SEC filings reveal massive selling in media names, including Disney and Comcast

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

How to buy Lumos Pharma (LUMO) shares